Statement of Principles concerning cut, stab, abrasion and laceration (Reasonable Hypothesis) (No. 37 of 2025)

The Statement centres on three principal legal‑medical concepts: the defined injury class, the threshold for connection ("reasonable hypothesis"), and the required service relationship.

Defined injury class. Section 7(2) gives the operative medical definition: cut, stab, abrasion and laceration is an injury that interrupts the continuity of the epidermis or other external or exposed tissue and causes a wound. The wound may or may not penetrate to subcutaneous tissues and underlying structures. The definition expressly includes friction burns and needlestick injury, and it lists specific exclusions: burns other than friction burns, dental abrasion, injury from explosive devices or fragments, gunshot, missile, and traumatic contusion or haematoma (section 7(2)(a)-(c) and the subitems). The Schedule repeats the definition reference and gives examples of "other external or exposed tissue" and defines related terms such as terminal event, MRCA and VEA.

Reasonable hypothesis threshold. The Statement is framed to identify the minimum factors that must exist for a reasonable hypothesis of service connection to be raised (section 9). The Repatriation Medical Authority records its view that sound medical‑scientific evidence indicates cut, stab, abrasion and laceration and death from those injuries can be related to relevant service (section 8). The Statement then stipulates that at least one of the listed factors must exist "as a minimum" before it can be said a reasonable hypothesis has been raised (section 9). The two enumerated factors are a direct physical trauma to the affected site at the time of the injury (section 9(1)) and inability to obtain appropriate clinical management for the injury before clinical worsening (section 9(2)). The title of the instrument also signals the standard: "Reasonable Hypothesis."

Service relationship. Section 10 sets the connection rules. Any factor that exists must be related to the relevant service rendered by the person (section 10(1)). Section 10(2) limits the application of the clinical management factor in section 9(2) so it applies only to material contribution to, or aggravation of, the injury where the injury was suffered or contracted before or during but did not arise out of the person’s relevant service.

Cross‑reference mechanism. Section 11 provides that if a factor in section 9 refers to an injury or disease covered by another Statement of Principles made under subsection 196B(2) of the VEA, then the factors in that other Statement "apply in accordance with the terms of that Statement of Principles as in force from time to time." That binds decision‑makers to apply the current terms of any relevant other Statements when the factor points to those injuries or diseases.

Definitions and scope. The Schedule defines "relevant service" to list the categories of VEA/MRCA service to which the instrument applies: operational, peacekeeping, hazardous, British nuclear test defence under the VEA, and warlike or non‑warlike service under the MRCA. The Schedule also defines "terminal event" by listing proximate or ultimate causes of death that are covered for the purpose of death claims (for example pneumonia, respiratory failure, cardiac arrest) and repeats the MRCA and VEA acronyms used elsewhere.

The instrument is addressed to claims that fall under specific provisions of the VEA and the MRCA. Section 5 states the Statement applies to a claim "to which section 120A of the VEA or section 338 of the MRCA applies." The Repatriation Medical Authority’s statutory statement of view in section 8 identifies the relevant populations as veterans, members of Peacekeeping Forces, members of the Forces under the VEA, and members under the MRCA; those are the classes of persons whose claims will engage this Statement.

In practice, the immediate operational effect reaches three groups.

Claimants and potential claimants. Any person seeking a decision under the VEA s120A or MRCA s338 in respect of cut, stab, abrasion and laceration, or death from such injuries, will be affected because the Statement sets the medical factors the decision‑maker must apply to determine whether a reasonable hypothesis has been raised (sections 5 and 9). Claimants who experienced an excluded mechanism , for example gunshot, missile, explosive fragment, or burns other than friction burns , will not have those incidents captured by this Statement (section 7(2)(c)-(h)). Claimants and their representatives will therefore need to align evidence to the defined injury type and to at least one of the factors in section 9.

Decision‑makers and assessors. The instrument is a rule‑making output of the Repatriation Medical Authority made under subsection 196B(2) of the VEA (section 3). The Statement supplies the medical‑scientific framework that decision‑makers charged with making determinations under the specified VEA and MRCA provisions will apply. Section 11 requires decision‑makers to give effect to other Statements where factors cross‑refer, applying those Statements "as in force from time to time", so a decision‑maker must be attentive to other RMA Statements and their current terms.

Health services and record‑keepers. The second enumerated factor in section 9 concerns inability to obtain appropriate clinical management before clinical worsening. Health services providers, administrative units responsible for records and any entity involved in the provision or denial of clinical treatment during or after a person’s service will be consequential actors because contemporaneous clinical records, referrals, treatment notes and access logs will be key evidence. The Schedule’s definition of "terminal event" also means medical certification of cause of death and proximate events will be material for death claims.

Organisations administering claims. Although the instrument does not name the claim administrator, it expressly applies to claims governed by the cited provisions of the VEA and MRCA (section 5). Organisations that administer those claims will need to use the Statement when assessing whether the medical evidence raises a reasonable hypothesis that the injury or death is related to relevant service.

The instrument does not create new beneficiaries or entitlements by itself; instead it shapes the evidentiary threshold for establishing a connection between the injury or death and relevant service for claims under specified statutory provisions.

This Statement of Principles sets evidentiary and interpretative duties for decision‑makers and evidence‑gathering duties for claimants, but it does not itself create statutory rights, entitlements or offences. The instrument’s operative duties and constraints are described in the following passages of the instrument and flow from its role under the VEA.

Duties imposed on decision‑makers. The Statement prescribes the minimum factors that "must as a minimum exist before it can be said that a reasonable hypothesis has been raised" connecting the injury or death to service (section 9). Decision‑makers applying the VEA s120A or MRCA s338 must therefore test whether at least one of the factors in section 9 is present and whether that factor is related to the person’s relevant service (section 10(1)). Where a factor in section 9 refers to an injury or disease that is the subject of another Statement of Principles, decision‑makers must also apply the factors in that other Statement "in accordance with the terms of that Statement ... as in force from time to time" (section 11). The instrument therefore creates an administrative duty to apply specified medical‑scientific criteria and to give effect to related Statements of Principles current at the time of decision.

Duty to establish the relationship to relevant service. Section 10(1) requires that any factor present be related to the person’s relevant service. This creates a factual link test that must be satisfied before the reasonable hypothesis threshold is reached. Section 10(2) clarifies the narrower operation of the clinical management factor in section 9(2): it applies only to material contribution or aggravation where the person’s injury was suffered or contracted before or during, but did not arise out of, the relevant service. That distinction restricts the clinical management factor to cases of contribution or aggravation in the specified temporal and causal circumstances.

Evidence duties for claimants. The Statement does not explicitly place a formal burden of proof on claimants; it sets the medical factors decision‑makers must find present to conclude a reasonable hypothesis has been raised (section 9). Claimants will need to produce or make available evidence capable of showing the presence of one or more of the enumerated factors and that the factor is related to relevant service. For example, to rely on section 9(1) a claimant would need evidence supporting an event of direct physical trauma to the relevant site at the time of injury; to rely on section 9(2) a claimant would need evidence showing inability to obtain appropriate clinical management before clinical worsening and link that failure in care to relevant service as constrained by section 10(2).

Rights in relation to other Statements. Section 11 operates as an integrative rule: where a factor refers to an injury or disease that is subject to another Statement, the factors in that other Statement apply "as in force from time to time." This gives claimants and decision‑makers the right to rely on the evolving content of other Statements of Principles in establishing causation for factors that point to those injuries or diseases.

No fines, penalties or private rights created by the Statement. The instrument contains no enforcement provisions, monetary penalties or private civil remedies. It is an administrative evidentiary instrument made under the VEA. Any rights to benefits, compensation or rehabilitation remain governed by the substantive provisions of the VEA and MRCA; the Statement informs the causation assessment that those provisions require.

Notice and temporal effect. The instrument commences on a specified date, 19 May 2025 (section 2), and repeals the prior 2016 Statement (section 4). Decision‑makers must take the commencement and repeal dates into account when determining which Statement governs a particular claim, particularly where facts straddle the repeal and commencement dates.

This Statement does not create criminal or civil penalties, enforcement sanctions, or administrative fines. The instrument is an evidentiary Statement of Principles made under subsection 196B(2) of the VEA (section 3). Its role is to articulate the medical‑scientific factors to be applied in assessing whether a reasonable hypothesis has been raised connecting an injury or death to relevant service for claims under specified provisions of the VEA and MRCA (section 5). The text contains no provisions imposing penalties or creating a new regulatory enforcement regime.

Enforcement in practice will therefore be administrative, exercised through the processes and decision‑making mechanisms established by the VEA and MRCA. The Statement determines what facts and medical factors "must as a minimum exist before it can be said that a reasonable hypothesis has been raised" (section 9). Administrative decision‑makers responsible for applying section 120A of the VEA or section 338 of the MRCA must assess evidence against the standards and definitions in this Statement. Where a decision‑maker finds the required factor and satisfies the service relationship in section 10, that finding will support an administrative determination that a reasonable hypothesis has been raised. Conversely, where the required factor is not established, the decision‑maker may find that no reasonable hypothesis has been raised. Any remedial, compensatory or rehabilitative outcome continues to be governed by the substantive statutes.

There are no specified enforcement mechanisms for ensuring compliance by health care providers, record‑keepers or other third parties with the Statement. The Statement’s evidentiary value will depend on the availability and quality of clinical records, witness statements and other material that decision‑makers can use in their statutory determinations.

Where an applicant disputes a decision that applies or interprets this Statement, the instrument itself does not set out appeal routes. Appeals and merits review, where available, are matters determined by the substantive statutes under which claims proceed. The Statement does not purport to override or modify statutory appeal mechanisms.

The Statement is expressly made under subsection 196B(2) of the VEA (section 3) and applies to claims to which section 120A of the VEA or section 338 of the MRCA applies (section 5). Its interaction with other laws and instruments is shaped by those references and by section 11, which provides for cross‑application of other Statements of Principles.

Interaction with the VEA and MRCA. The instrument is a statutory medical‑scientific instrument the Repatriation Medical Authority is authorised to make under the VEA. It does not amend or displace the substantive provisions of the VEA or MRCA; rather, it supplies the medical criteria that decision‑makers must apply when adjudicating causation questions under the specified claim provisions. The practical effect is that, for claims falling under VEA s120A or MRCA s338, the presence or absence of a factor in section 9 and its relationship to relevant service as required by section 10 will be a central evidentiary step in the adjudicative process.

Cross‑references to other Statements of Principles. Section 11 provides a mechanism for interoperability between Statements. If a factor in section 9 refers to an injury or disease covered by another Statement of Principles made under subsection 196B(2) of the VEA, the other Statement’s factors apply "in accordance with the terms of that Statement ... as in force from time to time." This creates an ongoing linkage: decision‑makers must consult and apply the current terms of other Statements when a factor in this Statement points to an injury or disease covered elsewhere. That means changes to other Statements can affect the operation of this Statement where there is overlap in medical causation chains.

Definitions and scope alignment. The Schedule defines the meaning of "relevant service" via categories drawn from both the VEA and MRCA: operational service, peacekeeping service, hazardous service, British nuclear test defence service under the VEA, and warlike or non‑warlike service under the MRCA. The alignment of terminology indicates this Statement is intended for use across both statutory regimes for the listed categories of service. The Schedule also defines "terminal event" for death claims, specifying proximate causes that the Statement treats as permissible terminal events for a death claim linked to the listed injuries.

Repeal and continuity. Section 4 repeals the earlier Statement No. 53 of 2016. The repeal means that claims falling to be assessed after the commencement date (19 May 2025) will be considered under this Statement unless another transitional arrangement is enacted elsewhere. The instrument does not contain express transitional provisions, so administrators must be attentive to the repeal date and the commencement date in applying the correct Statement to any claim.

Limitations and exclusions relative to other statutory provisions. The instrument lists specific exclusions from the defined injury class (for example gunshot, missile, explosive fragment, burns other than friction burns, dental abrasion, traumatic contusion or haematoma). Where an injury arises from an excluded mechanism, this particular Statement will not operate to raise a reasonable hypothesis. Decision‑makers will need to determine whether another Statement applies or whether the claim is governed by other provisions or definitions in the VEA or MRCA.

The Statement does not purport to modify statutory definitions or thresholds in other legislation outside its authority under subsection 196B(2) of the VEA. Its application is procedural and confined to the duties and claims identified in section 5 and to the medical factors it lists.

The instrument itself records a short amendment and replacement history. It is dated 15 April 2025 (the signature block) and "commences on 19 May 2025" (section 2). Section 4 expressly repeals the earlier Statement of Principles concerning cut, stab, abrasion and laceration No. 53 of 2016 (Federal Register of Legislation No. F2016L00567), which had been made under subsections 196B(2) and (8) of the VEA. The instrument does not record any intermediate amendments between the 2016 Statement and this 2025 Statement; it simply repeals the prior Statement and substitutes the new one.

The Schedule and body of the instrument contain definitions and the operative factors. The only instrument metadata present in the text are the instrument’s title, date, commencement date and the repeal of the 2016 instrument. There are no textual amendments, incremental updates, or revocations noted other than the single repeal. There are no transitional provisions included in this instrument text; the instrument therefore relies on the commencement date for its temporal effect.

Because section 11 refers to other Statements "as in force from time to time", the operation of this Statement may be affected by future amendments to other Statements. The instrument itself does not include a mechanism for automatic amendment beyond normal statutory processes; any change to this Statement would require a new determination under subsection 196B(2) of the VEA, or some other statutory mechanism authorised by the VEA, none of which are recorded here.

No subordinate instruments amending this Statement are listed in the text. The text does not include retroactivity clauses or special transitional treatment of existing claims that straddle the repeal and commencement dates. Administrators and practitioners should therefore note the key dates the instrument provides: dated 15 April 2025 and commencing 19 May 2025, with the 2016 Statement repealed as of the operation of this instrument (sections 1, 2 and 4).

The instrument does not include or refer to any litigation history. It cites no judicial decisions, and it does not identify any cases in which the Repatriation Medical Authority’s prior Statement No. 53 of 2016 was considered by a court or tribunal. The instrument is presented as a fresh Statement of Principles, replacing the 2016 Statement by repeal (section 4).

Because the text is limited to the Statement itself, there is no record within this instrument of administrative appeals, merits review outcomes, or judicial review proceedings arising from prior or current Statements. The instrument does not provide an annotated history of disputes, nor does it cite precedents or interpretative guidance from tribunals or courts. Any litigation or review history relevant to the application or interpretation of the factors in this Statement would therefore need to be sourced from decision records, tribunal determinations or court judgments external to this text. That material is not contained in the instrument.

Practitioners should note that section 11 cross‑references other Statements "as in force from time to time", so litigation that affects the content or interpretation of those other Statements could indirectly affect how this Statement operates in particular claims. The instrument itself, however, contains no litigation data.

This Statement is short and tightly framed, but it contains a number of potentially consequential features and pitfalls that practitioners should note, each grounded in the instrument’s text.

Narrow set of enumerated factors. Section 9 lists only two factors that "must as a minimum exist" to raise a reasonable hypothesis: (1) direct physical trauma to the affected site at the time of the injury and (2) inability to obtain appropriate clinical management for the injury before clinical worsening. There is no broader, free‑form catchall factor in the text. If a claimant’s causal case does not match one of those two factual situations, the instrument provides no additional medical factors to ground a reasonable hypothesis. That structure can make causation determinations hinge on precise factual characterisation of the event or care pathway.

Temporal and causal limitation on care‑access factor. Section 10(2) restricts the operation of section 9(2). The inability to obtain appropriate clinical management factor applies only to material contribution to, or aggravation of, the injury where the injury "was suffered or contracted before or during (but did not arise out of) the person's relevant service." The parenthetical "but did not arise out of" is a crucial limitation: the clinical management factor is not available where the injury itself was caused by the person’s relevant service (that scenario presumably falls within the direct trauma factor or other Statements). Practitioners should ensure they map the chronology of injury and service to this test, and not rely on section 9(2) where the injury arose out of service.

Exclusions in the definition. The definition of cut, stab, abrasion and laceration expressly excludes a list of mechanisms: burns other than friction burns, dental abrasion, explosive device or fragment thereof, gunshot, missile, and traumatic contusion or haematoma (section 7(2)). If an injury’s mechanism is one of these excluded causes, this Statement will not apply to that injury. Practitioners must assess mechanism carefully and consider whether another Statement of Principles or statutory pathway applies.

Death claims rely on "terminal event" definition. Death from cut, stab, abrasion and laceration is covered only where the death is from a terminal event or condition that was contributed to by the injury. The Schedule defines "terminal event" by listing examples (pneumonia, respiratory failure, cardiac arrest, circulatory failure, cessation of brain function). The listed examples indicate the types of proximate mechanisms the Statement contemplates for death claims, but the Schedule does not set an exhaustive test beyond "includes the following." Practitioners should therefore document proximate causes and medical pathways linking the injury to the terminal event.

Cross‑reference variability. Section 11 requires application of other Statements "as in force from time to time" when a section 9 factor refers to an injury or disease covered by another Statement. That creates a moving interplay: amendments to other Statements can affect whether the factor is satisfied. Practitioners should track relevant Statements and their current wording at the time of decision.

No transitional provisions stated. The instrument repeals the 2016 Statement (section 4) but does not state transitional rules for claims that straddle the repeal and commencement dates. Decision‑makers will need to determine which Statement governs a claim that was lodged or partially determined before commencement. The instrument itself provides no guidance on that point.

Evidentiary reliance on clinical records and access evidence. The clinical management factor in section 9(2) will typically require documentary evidence of attempts to obtain treatment, evidence of denial or unavailability, and clinical progression showing "clinical worsening." The instrument does not define "appropriate clinical management" or "clinical worsening." Those undefined terms inject interpretative discretion and may generate disputes about the sufficiency and quality of evidence required.

No penalties or enforcement mechanisms in the Statement. The instrument sets the medical criteria but contains no mechanisms to compel third parties to produce evidence or to sanction non‑production. Practical enforcement of document production and witness cooperation will depend on statutory processes external to the Statement.

Limited list of included injury types. Although the definition includes friction burns and needlestick injuries, it excludes dental abrasion and several high‑velocity or blast mechanisms. A claimant whose injury falls into a grey area between included and excluded categories must provide precise medical characterisation to establish the injury type.

Language of "reasonable hypothesis" not defined. The Statement repeatedly uses the phrase "reasonable hypothesis" but does not define the standard within the instrument. Users must apply the statutory meaning and administrative practice associated with that threshold in the VEA/MRCA context. The instrument does not itself expand or constrict that legal standard beyond the specified minimum factors.

This instrument functions as an evidentiary checklist and interpretative guide for causation assessments under specified claim provisions. Compliance for claimants, advisers and decision‑makers involves aligning evidence and reasoning to the precise terms of the Statement.

For claimants and representatives

• Map the injury to the instrument’s definition. Establish that the injury interrupts the continuity of the epidermis or other external or exposed tissue and causes a wound, and show it is not excluded by the express exclusions in section 7(2)(c)-(h). If relying on friction burn or needlestick examples, document the mechanism clearly.
• Demonstrate at least one section 9 factor. For section 9(1) document the event of direct physical trauma to the affected site at the time of injury, with contemporaneous incident reports, service records, medical treatment notes and witness statements. For section 9(2) document efforts to obtain clinical care, the denial or unavailability of appropriate treatment, and evidence of clinical deterioration that followed; contemporaneous requests for care, referral attempts, transport logs, and clinical notes will be relevant.
• Satisfy the service relationship test in section 10. Provide records linking the factor to the person’s relevant service category as defined in the Schedule (operational, peacekeeping, hazardous, British nuclear test defence, warlike, non‑warlike). For section 9(2) ensure the injury timeline fits the limitation in section 10(2) (that the injury was suffered or contracted before or during but did not arise out of the person’s relevant service) if relying on material contribution or aggravation.
• For death claims, obtain cause of death and terminal event documentation and connect the terminal event to the prior cut, stab, abrasion or laceration as contemplated by the Schedule’s terminal event examples.
• If a section 9 factor refers to an injury or disease covered by another Statement, identify and obtain the current terms of that other Statement to ensure compliance with section 11.

For decision‑makers and assessors

• Apply the precise textual tests. Before concluding a reasonable hypothesis is raised, confirm that at least one of the section 9 factors exists and that the factor is related to relevant service in accordance with section 10. Where a factor refers to another Statement, obtain and apply that Statement as currently in force (section 11).
• Verify injury classification and exclusion clauses. Check mechanisms against the exclusions in section 7(2) and classify the injury accordingly. If there is uncertainty about whether an injury falls within the defined class or an exclusion, document the basis for the conclusion and, if necessary, seek expert opinion that explicitly addresses the definitional elements in section 7(2).
• Document the basis for evaluations of "appropriate clinical management" and "clinical worsening." Because the Statement does not define those terms, assessment notes should set out the standards used, the evidence relied upon, and whether the clinical timeline satisfies the material contribution/aggravation limitation in section 10(2).
• Track other Statements of Principles. Because section 11 imports other Statements "as in force from time to time", decision‑makers must check for and apply any relevant subsequent Statements that bear on a referenced injury or disease.
• Observe commencement and repeal dates. Apply this Statement only to claims falling within its temporal application in accordance with its commencement date, and ensure that any claim for which the 2016 Statement might otherwise have applied is handled consistently with the repeal in section 4.

For health providers and record‑keepers

• Keep contemporaneous, detailed treatment and access records. Where an inability to obtain appropriate clinical management may be in issue, the presence or absence of contemporaneous referral notes, waitlist records, documented attempts to access care or denial of care will be salient.
• Use precise language. Where clinical notes describe wounds, indicate the tissue layers affected, the mechanism (for example, needlestick, friction burn, penetrating knife wound, contusion), and any progression to infection or other complications that could constitute clinical worsening.

For administrators

• Ensure internal processes reference this Statement for s120A VEA or s338 MRCA claims involving cut, stab, abrasion and laceration. Update evidence‑gathering checklists, decision templates and training materials to reflect the two enumerated factors, the definitional exclusions, and the cross‑reference rule in section 11.
• Establish procedures to determine which Statement applies in claims that straddle the repeal and commencement dates, in the absence of transitional language in the instrument.

Evidence quality and scope

• The Statement implies that the assessment is fact‑based. Where the available medical records do not clearly show direct trauma or documented attempts to obtain care, consider whether further enquiries, subpoenas or requests for records are appropriate within the administrative claim process. The Statement itself does not provide powers to compel production; those exist in the underlying statutory schemes and administrative practice, not in this instrument.

Record and reasoning

• Because the Statement is a tight, checklist style instrument, ensure that any reasons provided in decisions reference the relevant sections: identify the factor relied upon (section 9), explain how it is related to relevant service (section 10), and note whether any cross‑reference to another Statement was applied (section 11). This will assist in transparency and any subsequent review.

Concluding procedural note

• The Statement supplies the medical criteria for the "reasonable hypothesis" step. Claimants and decision‑makers should treat it as the primary medical reference point for the listed injury class in s120A and s338 claims, and should assemble and test evidence against the instrument’s specific text and defined terms.